🇫🇷
France · FR · FR:61932485
VOSEVI 400 mg/100 mg/100 mg, comprimé pelliculé
ReimbursedATC J05AP
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerGILEAD SCIENCES IRELAND UC (IRLANDE)
CountryFR (France)
ATC codeJ05AP
Dispensing—
ReimbursedYes
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009301102871 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant polypropylène de 28 comprimé(s)EUR 11.16
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "61932485",
"date_amm": "2017-07-26",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/17/1223",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}Related drugs
Other records sharing ATC code J05AP.
- 🇺🇸EpclusaGilead Sciences, Inc.
- 🇺🇸EpclusaGilead Sciences, Inc.
- 🇺🇸EpclusaGilead Sciences, Inc.
- 🇺🇸EpclusaGilead Sciences, Inc.
- 🇪🇸EPCLUSA 150 MG/37,5 MG GRANULADO RECUBIERTO EN SOBREGilead Sciences Ireland Unlimited Company
- 🇫🇷EPCLUSA 150 mg/37,5 mg, granulés enrobés en sachetGILEAD SCIENCES IRELAND UC (IRLANDE)
- GBEpclusa 150mg/37.5mg granules sachetsGilead Sciences Ltd
- 🇪🇸EPCLUSA 200 MG/50 MG GRANULADO RECUBIERTO EN SOBREGilead Sciences Ireland Unlimited Company
Access this data programmatically
Query VOSEVI 400 mg/100 mg/100 mg, comprimé pelliculé and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.